Literature DB >> 8907117

Expression of fibroblast growth factor binding protein HBp17 in normal and tumor cells.

T Okamoto, Y Tanaka, M Kan, A Sakamoto, K Takada, J D Sato.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8907117     DOI: 10.1007/bf02723035

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


× No keyword cloud information.
  36 in total

1.  Basic fibroblast growth factor fused to a signal peptide transforms cells.

Authors:  S Rogelj; R A Weinberg; P Fanning; M Klagsbrun
Journal:  Nature       Date:  1988-01-14       Impact factor: 49.962

2.  Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth.

Authors:  P W Finch; J S Rubin; T Miki; D Ron; S A Aaronson
Journal:  Science       Date:  1989-08-18       Impact factor: 47.728

3.  Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites.

Authors:  Y Myoken; Y Kayada; T Okamoto; M Kan; G H Sato; J D Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

4.  Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes.

Authors:  R S Morrison
Journal:  J Biol Chem       Date:  1991-01-15       Impact factor: 5.157

5.  Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells.

Authors:  A Tanaka; K Miyamoto; N Minamino; M Takeda; B Sato; H Matsuo; K Matsumoto
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

6.  Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene.

Authors:  T Miki; D P Bottaro; T P Fleming; C L Smith; W H Burgess; A M Chan; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

7.  Transformation of mouse BALB/c 3T3 cells with human basic fibroblast growth factor cDNA.

Authors:  R Sasada; T Kurokawa; M Iwane; K Igarashi
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

8.  Immunocytochemical localization of fibroblast growth factor-1 (FGF-1) and FGF-2 in oral squamous cell carcinoma (SCC).

Authors:  Y Myoken; Y Myoken; T Okamoto; J D Sato; K Takada
Journal:  J Oral Pathol Med       Date:  1994-11       Impact factor: 4.253

9.  Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors.

Authors:  F Czubayko; R V Smith; H C Chung; A Wellstein
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

10.  The release of fibroblast growth factor-1 from NIH 3T3 cells in response to temperature involves the function of cysteine residues.

Authors:  A Jackson; F Tarantini; S Gamble; S Friedman; T Maciag
Journal:  J Biol Chem       Date:  1995-01-06       Impact factor: 5.157

View more
  4 in total

1.  1α,25(OH)₂D₃ inhibits FGF-2 release from oral squamous cell carcinoma cells through down-regulation of HBp17/FGFBP-1.

Authors:  S N Zawani B Rosli; Tomoaki Shintani; Shigeaki Toratani; Emiko Usui; Tetsuji Okamoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-06-18       Impact factor: 2.416

2.  Anti-tumor effects of fibroblast growth factor-binding protein (FGF-BP) knockdown in colon carcinoma.

Authors:  Daniel Schulze; Philipp Plohmann; Sabrina Höbel; Achim Aigner
Journal:  Mol Cancer       Date:  2011-11-23       Impact factor: 27.401

3.  New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids.

Authors:  O A Patutina; N L Mironova; V V Vlassov; M A Zenkova
Journal:  Acta Naturae       Date:  2009-07       Impact factor: 1.845

4.  VEGF-A promotes the motility of human melanoma cells through the VEGFR1-PI3K/Akt signaling pathway.

Authors:  Koichi Koizumi; Tomoaki Shintani; Yasutaka Hayashido; Atsuko Hamada; Mirai Higaki; Yukio Yoshioka; Akihiko Sakamoto; Souichi Yanamoto; Tetsuji Okamoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2022-08-23       Impact factor: 2.723

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.